Mitochondrial quality control in lung diseases: current research and future directions
Jiliu Liu(Third People's Hospital of Chengdu), Xiang He(Third People's Hospital of Chengdu), Guoping Li(North Sichuan Medical University), Lei Zhang(Third People's Hospital of Chengdu), Yao Liu(Hebei Medical University), Junyi Wang(Nanjing University of Chinese Medicine), Ying Xiong(China-Japan Friendship Hospital), Yi Zhang(Tianjin Medical University General Hospital)
Cited by 37
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
The Brassica oleracea genome reveals the asymmetrical evolution of polyploid genomes
|Nature Communications|2014|1.2k